Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesobotox for Psoriasis Vulgaris
NCT06203470Phase 4Not yet recruiting
- Sponsor
- Assiut University
- Start
- Jun 2024
- Primary completion
- Jun 2026
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of Onabotulinumtoxina + hydrogel in Psoriasis vulgaris (PV), sponsored by Assiut University. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
Onabotulinumtoxina + hydrogel
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT06203470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06203470.